UMU logo

Group Leader at MIMS

MIMS ( seeks excellent young researchers who are interested in becoming new Group Leader for innovative research in Molecular Infection Medicine.

MIMS intends to finance one new Group Leader appointment in the coming year, and funding is primarily for a five-year period, with the possibility of extension up to a total of nine years after external evaluation in the fourth year.

Applicants should have documented successful research in areas relevant to molecular infection medicine. The recruited researchers will receive extensive support in order to establish their own research group with participants at postdoctoral and doctoral level.

Read more: Group Leader at MIMS

MIMS is recruiting! Postdocs and PhD students

MIMS is establishing new research groups and is now recruiting Postdocs and PhD students.

We are looking for qualified candidates interested in joining the highly interactive and multidisciplinary and international research environment for molecular infection medicine at Umeå University and two of our affiliated clinical research fellows at Lund University hospital and Karolinska Institutet. 

Several Postdoctoral Fellowships positions are available in the new laboratory of Oliver Billker (MIMS director from 1st October 2018).  The projects are part of a major effort funded by the European Research Council to systematically identify parasite gene functions in malaria transmission.

Read more: MIMS is recruiting! Postdocs and PhD students

MIMS seeks:

180703 GL MIMS 300x100

Billker lab postdoc fellowships

Cavalab Postdoc fellowship

Puharlab PhDstudent

Pahlmanlab Postdoc

Emmanuelle Charpentier:
MIMS is characterized by
ECharpentier about MIMS 2015 1

Emmanuelle Charpentier, Alumna at MIMS, now Director of the Max Planck Unit for the Science of Pathogens and Director of the Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Berlin, Germany.

Link to the Emmanuelle Charpentier Lab

footer all slides 2014-02-06

Copyright © 2017 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.